Effect of Zishenpingchan Granule on Neurobehavioral Manifestations and the Activity and Gene Expression of Striatal Dopamine D1 and D2 Receptors of Rats with Levodopa-Induced Dyskinesias

Effect of Zishenpingchan Granule on Neurobehavioral Manifestations and the Activity and Gene Expression of Striatal Dopamine D1 and D2 Receptors of Rats with Levodopa-Induced Dyskinesias

This study was performed to observe the effects of Zishenpingchan granule on neurobehavioral manifestations and the activity and gene expression of striatal dopamine D1 and D2 receptors of rats with levodopa-induced dyskinesias (LID). We established normal control group, LID model group, and TCM int...

Full description

Bibliographic Details
Main Authors:	Qing Ye, Xiao-Lei Yuan, Jie Zhou, Can-xing Yuan, Xu-ming Yang
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2014/342506

Similar Items

Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial
by: Qing Ye, et al.
Published: (2018-01-01)

Striatal neurons in the development of levodopa-induced dyskinesias in Parkinson’s disease
by: Alberico, Stephanie Lorraine
Published: (2017)

Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia
by: Stefania Sgroi, et al.
Published: (2018-07-01)

Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
by: Heiman, Myriam, et al.
Published: (2014)

Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
by: Rhyomi C. Sellnow, et al.
Published: (2019-01-01)

MALADAPTIVE PLASTICITY IN LEVODOPA-INDUCED DYSKINESIAS AND TARDIVE DYSKINESIAS: OLD AND NEW INSIGHTS ON THE EFFECTS OF DOPAMINE RECEPTOR PHARMACOLOGY
by: Antonio eCerasa, et al.
Published: (2014-04-01)

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
by: Chang-Qing Zheng, et al.
Published: (2021-06-01)

Behavioural and biochemical investigations into dyskinesia by levodopa or dopamine agonists in the MPTP-treated common marmoset
by: Maratos, Eleni Chryssa
Published: (2002)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
by: Tianbin Song, et al.
Published: (2021-03-01)

Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia
by: X. Zhou, et al.
Published: (2017-08-01)

Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson’s Disease
by: Satoshi Goto, et al.
Published: (2017-11-01)

Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats
by: Yang X, et al.
Published: (2012-04-01)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia
by: Nicola Tambasco, et al.
Published: (2012-01-01)

Dysregulation of BET proteins in levodopa-induced dyskinesia
by: David A. Figge, et al.
Published: (2017-06-01)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
by: Han Soo Yoo, et al.
Published: (2019-11-01)

Role of the level of expression of striatal dopamine transporter relative to striatal dopaminergic terminals in the pathogenesis of levodopa induced motor fluctuations in Parkinson’s disease
by: Koochesfahani, Kaveh M.
Published: (2009)

Role of the level of expression of striatal dopamine transporter relative to striatal dopaminergic terminals in the pathogenesis of levodopa induced motor fluctuations in Parkinson’s disease
by: Koochesfahani, Kaveh M.
Published: (2009)

L-DOPA-induced dyskinesia and abnormal signaling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission
by: Michael eFeyder, et al.
Published: (2011-10-01)

Investigation of KATP channels in levodopa -induced dyskinesia (LID)
by: Chia-HuiCheng, et al.
Published: (2018)

Levodopa-induced belly dancer's dyskinesia: Case report
by: José Renan Miranda Cavalcante-Filho, et al.
Published: (2020-01-01)

Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease
by: J Gordon Millichap
Published: (2012-07-01)

Future Scenarios for Levodopa-induced Dyskinesias in Parkinson’s disease
by: Antonio eCerasa, et al.
Published: (2015-04-01)

Effect of Deep Brain Stimulation on Levodopa-Induced Dyskinesias and Striatal Oscillatory Local Field Potentials in a Rat Model of Parkinson's Disease
by: M. Alam, et al.
Published: (2014-01-01)

NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology
by: Manuela Mellone, et al.
Published: (2019-01-01)

Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia
by: Melanie Hamann, et al.
Published: (2004-06-01)

Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced Dyskinesia
by: Michael L. Martini, et al.
Published: (2019-09-01)

Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia
by: Pedro eBarroso Chinea, et al.
Published: (2010-09-01)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
by: Bargiotas P, et al.
Published: (2013-10-01)

Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice
by: Mokarian Faezeh, et al.
Published: (2018-12-01)

Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network
by: Asha eKishore, et al.
Published: (2014-08-01)

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01)

White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
by: Seok Jong Chung, et al.
Published: (2020-02-01)

Treatment of Levodopa-induced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
by: Amir Hassan Habibi, et al.
Published: (2018-10-01)

Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
by: Mario Gustavo Murer, et al.
Published: (2011-08-01)

Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats
by: Song L,Yuan W, et al.
Published: (2012-11-01)

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats
by: Xuebing Cao, et al.

STRIATAL ACETYLCHOLINE-DOPAMINE INTERACTIONS IN PHYSIOLOGY AND PATHOPHYSIOLOGY
by: Cai, Yuan
Published: (2021)

Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
by: Michael H. Li, et al.
Published: (2018-11-01)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01)

The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias
by: Vishakh Iyer, et al.
Published: (2021-11-01)